Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Fury MG, Sherman EJ, Rao SS. et al.
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).

Ann Oncol 2014;
25 (03) 689-694

Bibliographische Angaben herunterladen

Aufrufen in: